drugset / Trial / NCT01796795
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This phase II study is to evaluate the efficacy of SR-T100 gel in complete clearance of target warts at different concentrations (1.0% and 2.3% of SM in Solanum undatum plant extract) in patients with CW.
Timeline
- Start
- 2030-09
- Primary completion
- 2033-04
- Completion
- 2033-08
Outcome
Outcome not reported
Stopped: “Budget issue.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SR-T100 | Unknown | 1 % | Topical |
| Comparator | SR-T100 | Unknown | 2.3 % | Topical |